Status:
RECRUITING
Bridge-Enhanced ACL Repair (BEAR) in Meniscus Repair
Lead Sponsor:
NYU Langone Health
Conditions:
Meniscus Tear
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The bridge-enhanced ACL repair (BEAR) implant is a collagen-based scaffold loaded with whole blood. It is designed to promote healing in the setting of intraarticular knee pathology. This study would ...
Eligibility Criteria
Inclusion
- • History of meniscus injury indicated for isolated repair, without concomitant ligament reconstruction or repair, cartilage repair procedure, or osteotomy.
Exclusion
- Patients who are undergoing meniscal repair for displaced bucket-handle meniscal tears
- Patients with a history of blood-borne diseases including HIV, hepatitis B virus, hepatitis C virus, human T-lymphotropic virus, and syphilis
Key Trial Info
Start Date :
November 20 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2026
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06041763
Start Date
November 20 2024
End Date
November 1 2026
Last Update
April 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Langone Health
New York, New York, United States, 10016